Formulation and Evaluation of Esomeprazole Magnesium delayed release Tablets 40MG

International Journal of Research and Applications ◽

10.17812/ijra.2.6(45)2015 ◽

2015 ◽

Vol 2 (6) ◽

pp. 242-252

Author(s):

Jagadeesh Kumar Ega

Keyword(s):

Delayed Release ◽

Esomeprazole Magnesium

Download Full-text

Esomeprazole Magnesium Delayed-Release Capsules

10.31003/uspnf_m30590_05_01 ◽

2021 ◽

Keyword(s):

Delayed Release ◽

Esomeprazole Magnesium

Download Full-text

Prediction of In-vivo Performance of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets using Biorelevant Dissolution Tests

Asian Journal of Pharmaceutical Research and Health Care ◽

10.18311/ajprhc/2020/25237 ◽

2020 ◽

Vol 12 (2) ◽

pp. 12-23

Author(s):

Devi Thamizhanban ◽

Gampa Tulja Rani ◽

Kathiresan Krishnasamy ◽

◽

◽

...

Keyword(s):

Delayed Release ◽

Biorelevant Dissolution ◽

Dissolution Tests ◽

Esomeprazole Magnesium

Download Full-text

In Vitro Evaluation of Nasogastric Tube Delivery Performance of Esomeprazole Magnesium Delayed-Release Capsules

Journal of Pharmaceutical Sciences ◽

10.1016/j.xphs.2017.04.008 ◽

2017 ◽

Vol 106 (7) ◽

pp. 1859-1864 ◽

Author(s):

Alicia Hoover ◽

Dajun Sun ◽

Hong Wen ◽

Wenlei Jiang ◽

Minglei Cui ◽

...

Keyword(s):

Nasogastric Tube ◽

In Vitro Evaluation ◽

Delivery Performance ◽

Delayed Release ◽

Esomeprazole Magnesium

Download Full-text

Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies

Journal of Thrombosis and Thrombolysis ◽

10.1007/s11239-013-1035-4 ◽

2013 ◽

Vol 38 (1) ◽

pp. 11-23 ◽

Author(s):

Dominick J. Angiolillo ◽

Catherine Datto ◽

Shane Raines ◽

Neville D. Yeomans

Keyword(s):

Drug Therapy ◽

Low Dose ◽

Phase Iii ◽

Inflammatory Drug ◽

Delayed Release ◽

Dose Aspirin ◽

Low Dose Aspirin ◽

Anti Inflammatory ◽

Esomeprazole Magnesium ◽

Phase Iii Studies

Download Full-text

Oral azathioprine delayed-release (AZA-DR) delivers AZA to the ileum/colon with less systemic exposure than occurs with imuran®

Gastroenterology ◽

10.1016/s0016-5085(01)83108-5 ◽

2001 ◽

Vol 120 (5) ◽

pp. A625-A625

Author(s):

B HEPBURN ◽

B GOLDLUST ◽

C LUBIN

Keyword(s):

Systemic Exposure ◽

Delayed Release

Download Full-text

Patanase Nasal Spray, Prilosec Delayed- Release Oral Suspension

Pediatric News ◽

10.1016/s0031-398x(08)70230-3 ◽

2008 ◽

Vol 42 (5) ◽

pp. 31

Author(s):

DAMIAN MCNAMARA

Keyword(s):

Nasal Spray ◽

Oral Suspension ◽

Delayed Release

Download Full-text

Lodotra (delayed release prednisone) is variably absorbed, and should not be used in adrenal insufficiency

Endocrine Abstracts ◽

10.1530/endoabs.50.p186 ◽

2017 ◽

Author(s):

Jennifer Zhang ◽

Sirazum Choudhury ◽

Karim Meeran

Keyword(s):

Adrenal Insufficiency ◽

Delayed Release

Download Full-text

Delayed-release dimethyl fumarate demonstrated no evidence of difference in clinical outcomes vs fingolimod in patients with RRMS: a propensity-matched comparative effectiveness analysis of the German NeuroTransData registry

10.26226/morressier.59a3eda8d462b8028d895362 ◽

2017 ◽

Author(s):

Stefan Braune

Keyword(s):

Clinical Outcomes ◽

Comparative Effectiveness ◽

Dimethyl Fumarate ◽

Delayed Release ◽

Effectiveness Analysis ◽

Comparative Effectiveness Analysis

Download Full-text

Efficacy of Delayed-release Dimethyl Fumarate in Newly Diagnosed Patients With Relapsing-Remitting Multiple Sclerosis: Eight-Year Follow-up of an Integrated Analysis of DEFINE, CONFIRM, and ENDORSE

10.26226/morressier.59a3eda8d462b8028d895222 ◽

2017 ◽

Author(s):

Ralf Gold

Keyword(s):

Multiple Sclerosis ◽

Dimethyl Fumarate ◽

Integrated Analysis ◽

Newly Diagnosed ◽

Delayed Release ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Delayed-release Dimethyl Fumarate Demonstrated No Difference in Clinical Outcomes versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Real-world EFFECT Study

10.26226/morressier.59a3e8b6d462b8028d8951f5 ◽

2017 ◽

Author(s):

Jacob Sloane

Keyword(s):

Multiple Sclerosis ◽

Clinical Outcomes ◽

Dimethyl Fumarate ◽

Effect Study ◽

The Real ◽

Delayed Release ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text